“Basically, the responses were, ‘What can we do to help you?'” Dan Liljenquist, senior vice president and chief strategy officer of Salt Lake City-based Intermountain Healthcare told STAT.
The collaboration of seven major health system will begin by manufacturing 14 hospital-administered generic drugs that have been in short supply.
Interest from those regulators mirrors the Trump administration’s focus on bringing down drug prices and improving drug shortages.
But after meeting with the regulators, Mr. Liljenquist said the company doesn’t have much to ask for from the FDA or Capitol Hill.
“We said, look: Just apply the same rules you apply to everybody else to us, and that’s all we need,” Mr. Liljenquist told STAT. “We are not looking to Washington to solve this issue.”
Read the full report here.
More articles on pharmacy:
20 generic drugmakers must answer price-fixing lawsuit
Novartis strikes $2.1B deal to buy cancer drugmaker Endocyte
Insys tactics to hike fentanyl sales detailed in Missouri senator’s report
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
